Visa delivered robust financial performance in fiscal 2024, with net revenue increasing 10% to $35.9 billion and net income rising 14% to $19.7 billion. The growth was primarily driven by a 14% ...
Tencent'slatest earnings report sends a clear signal: AI investment is rapidly translating into revenue growth. Multiple business lines, including gaming, adv ...
On the afternoon of July 18, Lei Jun, the founder of Xiaomi Technology Co., Ltd., announced that the "Xiaomi Shenzhen Building," located by the Shenzhen Bay, officially opened today. At the same time, ...
A leading hedge fund manager predicts that the main investment theme in AI is set to shift, with the next wave of opportunities likely to favor companies that leverage AI to enhance productivity and ...
Goldman Sachs: Microsoft’s AI investment enters a new phase, with market focus shifting to returns
1. Goldman Sachs projects that Microsoft's Azure revenue growth rate may reach 46%–47% in the first quarter of fiscal year 2027; 2. Microsoft's capital expenditure for fiscal year 2027 is expected to ...
BenjaminBaum, senior exterior design director at Li Auto, introduces the Li i6, known as the Li 6 in Europe, on the opening day of the Paris auto show on Octo ...
10-K:Micron Technology | 10-K: FY2025 Annual Report Google's Q3 results fell short of expectations, with free cash flow plunging and growing skepticism over the return on its AI investments. Google ...
MainpointsThe acceleration in hardware spending is driven primarily by cyclical factors rather than structural demand from AI. By 2027, hardware expenditures ...
MainpointsThe 2026 capital expenditure (Capex) growth forecast for cloud data centers has been revised upward to 85%, driven by accelerated investment in arti ...
â‘ The core question the market most urgently seeks to answer is: Who will be the 'next supply bottleneck' in the AI supply chain? â‘¡ Goldman Sachs believes the answer may lie in an unassuming and ...
MainpointsPost-election asset rallies in Brazil reflect optimism about fiscal reform, yet the path to debt sustainability remains fraught with challenges. The ...
Barclaysanalyst Etzer Darout maintains $Legend Biotech(LEGN.US)$ with a buy rating, and adjusts the target price from $74 to $68.According to TipRanks data, t ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results